Send feedback

LRP2 p.Ser2019=

c.6057A>G · rs150970767 · VCV1559954

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
rare (popmax 0.108%, afr)
Conditions
1
Donnai-Barrow syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.55GERP -0.11, phastCons 1
Overall
CADD7.339PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.108% African / African-American · 81/75,050 alleles
Filtering AF 0.0889% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.082%
Overall 0.00576% 93/1,614,084 alleles · rare exomes 51/1,461,724 · genomes 42/152,360 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.108% 927
Remaining individualsnot grpmax-eligible 0.0128% 7,813
Admixed American 0.00667% 15,000

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
LRP2
Protein
p.Ser2019=
Coding
c.6057A>G
MANE Select
NM_004525
dbSNP
rs150970767
Type
single nucleotide variant
Location
chr2:169212191 (GRCh38)
Gene constraint
LOEUF 0.352 · pLI 1.00 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Full LRP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lrp2-p-ser2019 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown